JCN037

Research use only, not for human use.

JCN037 is potent, non-covalent and brain-penetrant inhibitor of EGFR(EGFR, p-wtEGFR and pEGFRvⅢ with IC50 of 2.49 nM, 3.95 nM, 4.48 nM , respectively).

JCN037 is potent, non-covalent and brain-penetrant inhibitor of EGFR(EGFR, p-wtEGFR and pEGFRvⅢ with IC50 of 2.49 nM, 3.95 nM, 4.48 nM , respectively).Relative to the conventional EGFR TKIs erlotinib and lapatinib, JCN037 displayed potent activity against EGFR amplified/mutant patient-derived cell cultures, significant BBB penetration (2:1 brain-to-plasma ratio), and superior efficacy in an EGFR-driven orthotopic glioblastoma xenograft model.

——

Angiogenesis

EGFR

EGFR

——

——

2305154-31-6

376.18

C16H11BrFN3O2

>98% (HPLC)

——

Fc1c(Br)cccc1Nc1ncnc2cc3OCCOc3cc12

——

(-20℃)

With Ice Pack

≥ 2 years